Caditraz 2.5mg Tablet

About

Caditraz 2.5mg Tablet is an aromatase inhibitor, a class of medication primarily used in the treatment of hormone-receptor-positive breast cancer in postmenopausal women. It works by blocking the enzyme aromatase, which is responsible for converting androgens into estrogens in peripheral tissues. By significantly reducing estrogen levels in the body, Caditraz effectively inhibits the growth of estrogen-dependent breast cancer cells. This targeted approach makes it a crucial therapy for both early-stage and advanced breast cancer, often prescribed as adjuvant therapy after surgery, or for metastatic disease. Its mechanism helps to prevent recurrence and progression of the disease, offering a significant benefit to patients whose cancers are sensitive to hormonal manipulation.

Uses

• Adjuvant treatment of early breast cancer
• Extended adjuvant treatment of early breast cancer
• First-line treatment of advanced breast cancer
• Treatment of advanced breast cancer after anti-estrogen therapy

Directions For Use

Take one tablet orally once daily, with or without food, as prescribed by your physician.

Benefits

• Significantly reduces estrogen levels
• Inhibits the growth of hormone-sensitive breast cancer
• Lowers the risk of cancer recurrence
• Improves disease-free survival
• Effective in both early and advanced stages
• Convenient oral administration

Side Effects

• Hot flashes
• Joint pain (arthralgia)
• Fatigue
• Nausea
• Headache
• Dizziness
• Bone thinning (osteoporosis)
• Increased cholesterol levels
• Sweating
• Weight gain
• Hair thinning
• Vaginal dryness

Safety Measures

• Alcohol - No specific interaction, but moderation is advised. Consult your doctor regarding alcohol consumption.
• Pregnancy - Caditraz is contraindicated during pregnancy as it may cause fetal harm. Effective contraception is required for women of childbearing potential.
• Breastfeeding - It is unknown if Caditraz is excreted in human milk. Due to potential serious adverse effects, breastfeeding is contraindicated.
• Liver - Use with caution in patients with severe hepatic impairment; dose adjustment may be needed.
• Kidney - No dose adjustment is typically required for mild to moderate renal impairment. Use with caution in severe impairment.
• Lung - No specific concerns or contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.